Oxidative changes in cerebral spinal fluid phosphatidylcholine during treatment for acute lymphoblastic leukemia

Biological Research for Nursing

Volumn 6, Issue 3, 2005, Pages 187-195

  Miketova, Petra ^a   Kaemingk, Kris ^b   Hockenberry, Marilyn ^c   Pasvogel, Alice ^a   Hutter, John ^b   Krull, Kevin ^d   Moore, Ida M ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c TEXAS CHILDREN S HOSPITAL   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Childhood leukemia; Lipid peroxidation; Methotrexate; Oxidative stress; Phosphatidylcholine

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; METHOTREXATE; PHOSPHATIDYLCHOLINE;

ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; CEREBROSPINAL FLUID; CHILD; DISEASE FREE SURVIVAL; DRUG EFFECT; FEMALE; HUMAN; INTRASPINAL DRUG ADMINISTRATION; LIPID PEROXIDATION; MALE; MORTALITY; OXIDATIVE STRESS; PRESCHOOL CHILD;

ADOLESCENT; ANTIMETABOLITES, ANTINEOPLASTIC; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INJECTIONS, SPINAL; LEUKEMIA, LYMPHOCYTIC, ACUTE; LIPID PEROXIDATION; MALE; METHOTREXATE; OXIDATIVE STRESS; PHOSPHATIDYLCHOLINES;

EID: 16644366977     PISSN: 10998004     EISSN: 15524175     Source Type: Journal    
DOI: 10.1177/1099800404271916     Document Type: Article

References (39)

1. Babiak RMV, Campello AP, Carnieri EGS, Oliveira MBM. 1998. Methotrexate: pentose cycle and oxidative stress. Cell Biochem Funct 16:283-93.
2. Blair IA. 2001. Lipid hydroperoxide-mediated DNA damage. Exp Gerontol 36:1473-81.
3. Borst JW, Visser NV, Kouptsova O, Visser AJWG. 2000. Oxidation of unsaturated phospholipids in membrane bilayer mixtures is accompanied by membrane fluidity changes. Biochim Biophys Acta 1487:61-73.
4. Brown RT, Sawyer MB, Antoniuo G, Toogood I, Rice M, Thompson N, Madan-Swain A. 1996. A 3-year follow-up of the intellectual and academic functioning of children receiving central nervous system prophylactic chemotherapy for leukemia. J Dev Behav Pediatr 17:392-8.
5. Chan PH. 2001. Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab 21:2-14.
6. Espy KA, Moore, IM, Kaufmann PM, Kramer JH, Matthay K, Hutter JJ. 2001. Chemotherapeutic CNS prophylaxis and neuropsychologic change in children with acute lymphoblastic leukemia: a prospective study. J Pediatr Psychol 26:1-9.
7. Evans AE, Gilbert SE, Zandstra R. 1970. The increasing incidence of central nervous system leukemia in children. Cancer 26:404-9.
8. Farooqui AA, Horrocks LA. 1998. Lipid peroxides in the free radical pathophysiology of brain diseases. Cell Mol Neurobiol 18:599-608.
9. Folch J, Lees M, Stanley GHS. 1957. A simple method for the isolation and purification of total lipids from animal tissue. J Biol Chem 226:497-509.
10. Genestier L, Paillot R, Quemeneur l, Izeradjene K, Revillard JP. 2000. Mechanisms of action of methotrexate. Immunopharmacol 47:247-57.
11. Giralt J, Ortega JJ, Olive T, Verges R, Forio I, Salvador L. 1992. Long-term neuropsychologic sequelae of childhood leukemia: comparison of two CNS prophylactic regimens. Int J Radiat Oncol Biol Phys 24:49-53.
12. Girotti AW. 1998. Lipid hydroperoxide generation, turnover, and effector action in biological systems. J Lipid Res 39:1529-42.
13. Gniwotta C, Morrow JD, Roberts LJ II, Kuhn H. 1997. Prostaglandin F2-like compounds, F2-isoprostanes, are present in increased amounts in human atherosclerotic lesions. Arterioscler Thromb 17:3236-41.
14. Halliwell B, Gutteridge JMC. 1990. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 186:1-85.
15. Hill DE, Ciesielski KT, Sethre-Hofstad L, Duncan MH, Lorenzi M. 1997. Visual and verbal short-term memory deficits in childhood leukemia survivors after intrathecal chemotherapy. J Pediatr Psychol 22:861-70.
16. Illingworth DR, Glover J. 1971. The composition of lipids in cerebrospinal fluid of children and adults. J Neurochem 18:769-76.
17. Jahovic N, Cevik H, Sehirli AO, Yegan BC, Sener G. 2003. Melatonin prevents methotrexate-induced hepatorenal oxidative injury in rats. J Pineal Res 34:282-7.
18. Janjua N, Mayer SA. 2003. Cerebral vasospasm after subarachnoid hemorrhage. Curr Opin Crit Care 9:113-9.
19. Jira W, Spiteller G, Schramm A. 1996. Increase in hydrox fatty acids in human low density lipoproteins with age. Chem Phys Lipids 84:165-73.
20. Kaemingk KL, Carey ME, Moore IM, Herzer M, Hutter JJ. 2004. Math deficits in survivors of acute lymphoblastic leukemia. Child Neuropsychol. Forthcoming.
21. Lesnik PG, Ciesielski KT, Hart BL, Benzel EC, Sanders JA. 1998. Evidence for cerebellar-frontal system changes in children treated with intrathecal chemotherapy for leukemia. Arch Neurol 55:1561-8.
22. Linet MS, Ries LAG, Smith MA, Tarone RE, Devesa SS. 1999. Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States. J Natl Cancer Inst 91:1051-8.
23. Lloberas N, Torras J, Herrero-Fresneda I, Cruzado JM, Riera M, Hurtado I, Grinyo JM. 2002. Postischemic renal oxidative stress induces inflammatory response through PAF and oxidized phospholipids: prevention by antioxidant treatment. FASEB J 16:908-10.
24. Margolin JF, Steuber CP, Poplack DG. 2002. Acute lymphoblastic leukemia. In: Pizzo PA Poplack DG, editors. Principles and practice of pediatric oncology. 4th ed. Philadelphia: Lippincott, Williams & Wilkins.
25. Mawatari S, Murakami K. 1998. Analysis of membrane phospholipid peroxidation by isocratic high-performance liquid chromatography with ultraviolet detection. Anal Biochem 264:118-23.
26. Merkle CJ, Moore IM, Penton BS, Torres BJ, Cueny RK, Schaeffer RC, Montgomeiy DW. 2000. Methotrexate causes apoptosis in postmitotic endothelial cells. Biol Res Nurs 2:5-14.
27. Moore IM, Espy KA, Kaufmann PH, Kramer JH, Kaeningk K, Miketova P, Mollova N, Kaspar M, Pasvogel A, Schram K, and others. 2000. Cognitive consequences and central nervous system injury following treatment for childhood leukemia. Semin Oncol Nurs 16:279-90.
28. Mulhern RK, Fairclough D, Oches J. 1991. A prospective comparison of neuropsychological performance of children surviving leukemia receiving 18-Gy, 24-Gy, or no cranial radiation. J Clin Oncol 9:1348-56.
29. Navab M, Hama SY, Ready ST, Ng CJ, Van Lenter BJ, Laks H, Fogelman AM. 2002. Oxidized lipids as mediators of coronary heart disease. Curr Opin Lipidol 13:363-72.
30. Ravindranath Y. 2003. Recent advances in pediatric acute lymphoblastic and myeloid leukemia. Curr Opin Oncol 15:23-35.
31. Raymond-Speden E, Tripp G, Lawrence B, Holdaway D. 2000. Intellectual, neuropsychological, and academic functioning in long-term survivors of leukemia. J Pediatr Psychol 25:59-68.
32. Spiteller G. 2001. Lipid peroxidation in aging and age-dependent diseases. Exp Gerontol 36:1425-57.
33. Subbanagounder G, Watson AD, Berliner JA. 2000. Bioactive products of phospholipid oxidation: isolation, identification, measurement and activities. Free Rad Biol Med 28:1751-61.
34. Subbara KV, Richardson JS, Ang LC. 1990. Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro. J Neurochem 55:342-5.
35. Treggiari-Venzi MM, Suter PM, Romand JA. 2001. Review of medical prevention of vasospasm after aneurismal subarachnoid hemorrhage: a problem of neurointensive care. Neurosurg 48:249-62.
36. Waber DP, Tarbell NJ, Fairclough D, Atmore K, Castor R, Isquith P, Lussier F, Romero I, Carpenter PJ, Schiller M, and others. 1995. Cognitive sequelae of treatment in childhood acute lymphoblastic leukemia: cranial radiation requires an accomplice. J Clin Oncol 13:2490-6.
37. Wang T, Powell WS. 1991. Increased levels of monohydroxy metabolites or arachidonic acid and linoleic acid in LCL and aorta from atherosclerotic rabbits. Biochim Biophys Acta 1084:129-38.
38. Weber GF. 1994. The pathophysiology of reactive oxygen intermediates in the central nervous system. Med Hypotheses 43:223-30.
39. Zaleska MM, Wilson DF. 1989. Lipid hydroperoxides inhibit reacylation of phospholipids in neuronal membranes. J Neurochem 52:255-60.